Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Molecular Partners Ag (OP: MLLCF )

4.530 -0.470 (-9.40%)
Streaming Delayed Price Updated: 9:53 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 300
Open 5.200
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 5.000
Today's Range 4.530 - 5.200
52wk Range 3.800 - 6.700
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbbVie Returns Eye Drug Candidate To Molecular Partners
AbbVie Inc (NYSE: ABBV) has terminated its license and collaboration agreement with Molecular Partners AG (NASDAQ: MOLN) for abicipar pegol for... 
Via Benzinga
Cowen Initiates Coverage On Molecular Partners With Price Target Of $50
Cowen & Co initiated coverage on Molecular Partners (NASDAQ: MOLN) with an Outperform rating and a Price Target of $50, implying an upside potential of... 
Via Benzinga

Performance

YTD
+9.16%
+9.16%
1 Month
N/A
N/A
3 Month
+0.67%
+0.67%
6 Month
+17.66%
+17.66%
1 Year
+15.27%
+15.27%

More News

Read More
Molecular Partners - Novartis' COVID-19 Antiviral Shows Encouraging Preclinical Action Against Delta Variant
Via Benzinga
Exposures COVID-19
Novartis Looks To Enter mRNA Technology, Says Chairman: Reuters
Via Benzinga
Novartis, Molecular Partners Initiate Global Trial For COVID-19 Treatment
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.